Medpage Today on MSN5d
Weekend Warriors and Dementia; Iron Chelation and Alzheimer's; Neuro Drug Costs RiseOut-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...
While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...
Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...
Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...
Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...
Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...
NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...
Should Alzheimer’s be diagnosed without symptoms? Proposal to rely on blood tests roils scientists
Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...
The data were presented at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference. Nilotinib is a tyrosine kinase ...
New research reveals that lecanemab, an Alzheimer's drug previously hailed for slowing disease progression, may increase the risk of death by 25%. The study found a tripled risk of death within a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback